Cargando…
Environmental impact of the reported chromatographic methods for the determination of the first FDA-Approved therapy for COVID-19 Patients, Remdesivir: A comparative study
Remdesivir (REM) is considered the first therapeutic option approved by US Food and Drug Administration (FDA) for clinical care in case of hospitalized patients suffering in COVID-19 epidemic. In the presented multilateral comparative search, four eco friendlessness approaches —National Environmenta...
Autores principales: | Ahmed, Amal B., Gamal, Mohammed, Naguib, Ibrahim A., Ali, Hazim M., Abdallah, Fatma F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801062/ https://www.ncbi.nlm.nih.gov/pubmed/35125520 http://dx.doi.org/10.1016/j.microc.2022.107242 |
Ejemplares similares
-
Remdesivir: the first FDA-approved anti-COVID-19 Treatment for Young Children
por: Chera, Alexandra, et al.
Publicado: (2022) -
Remdesivir: First Approval
por: Lamb, Yvette N.
Publicado: (2020) -
Eco-friendly spectrophotometric methods for determination of remdesivir and favipiravir; the recently approved antivirals for COVID-19 treatment
por: Elama, Heba Samir, et al.
Publicado: (2023) -
First vaccine approval under the FDA Animal Rule
por: Beasley, David W C, et al.
Publicado: (2016) -
Immunotherapy for Breast Cancer: First FDA Approved Regimen
por: Soare, Georgiana R., et al.
Publicado: (2019)